Garmin Venu 4 Shines Bright: Wellness Coach, Flashlight & Big Upgrades to Rival Apple Watch
29 October 2025
4 mins read

Garmin’s Big Q3 Surprise: Record Sales Surge, but Stock Plummets – What’s Next?

  • Record Q3 Performance: Garmin reported ~$1.77–$1.8 billion in third-quarter revenue (up ~12% YoY)prnewswire.com. GAAP EPS was $2.08 (pro forma $1.99)prnewswire.com, narrowly above Street expectations.
  • Stock Reaction: Despite the sales beat, Garmin shares fell sharply (~7%) on Oct. 29 as revenue slightly missed consensusuk.investing.com. The stock had been up ~17% YTDtipranks.com, but the miss spooked investors.
  • Raised Guidance: Management raised full-year 2025 guidance to $8.15 EPS and $7.10 billion revenuetimesunion.comprnewswire.com. Garmin now expects margins around 58.5% gross and 25.2% operating for FY251 .
  • Segment Growth: The fitness segment led the charge (+30% to $601 M)uk.investing.com. New product launches – including the Venu® 4 smartwatch (with built-in flashlight) and the Bounce™ 2 kids’ tracker – helped drive growthprnewswire.com. Garmin also launched its first satellite-capable fēnix® 8 Pro outdoor watch2 .
  • Analyst Outlook: Wall Street is divided. Tigress Financial (Strong-Buy) upped its Garmin target to $305tipranks.com, citing accelerating wearables demand. By contrast, the median analyst target is only ~$210tickernerd.com, implying modest upside. Weiss Ratings also reiterated a Buy, noting recent target raises (JPMorgan to $250, Tigress to $305)3 .
  • Legal Headwinds: Tech media highlights a patent suit by fitness app Strava, filed Sept. 30ts2.tech. Strava seeks to halt Garmin’s use of its patented “segments” and “heatmap” features – actions that could hit Garmin’s watches and bike computers hardts2.tech4 .

Garmin Q3 2025 Earnings Beat Expectations

Garmin’s Oct. 29 press release showed record Q3 sales of ≈$1.77 billionprnewswire.com, up 12% from a year ago. CEO Cliff Pemble lauded “another quarter of strong financial results” with double-digit revenue growth in multiple segmentsuk.investing.com. Adjusted profit was $1.99 per share (versus $1.98 expected)uk.investing.com. On a GAAP basis EPS was $2.08prnewswire.com, essentially flat YoY. The strong demand came despite a slowing economy, reflecting Garmin’s diverse portfolio (fitness wearables, marine and aviation equipment, etc.). Notably, Garmin reiterated bullish guidance: it now expects about $8.15 EPS for FY2025 on roughly $7.10 billion revenuetimesunion.com5 .

Stock Slides on Slight Sales Miss and Outlook

Even with solid earnings, Garmin shares tanked around 7% in pre-market trading on Oct. 29uk.investing.com. Investors fixated on the narrow sales shortfall: Q3 revenue was $1.77B, just under the $1.78–1.80B consensusuk.investing.com. Full-year revenue guidance of $7.10B also came in slightly below analysts’ $7.16B forecastuk.investing.com. As Investing.com notes, the stock “fell 7.29%” after hours despite an earnings beatuk.investing.com. Garmin’s recent trading history has been volatile – it’s up roughly 17% YTDtipranks.com, but a week of profit-taking or any new headwinds could quickly reverse gains. (For context, Garmin closed around $248/share just before earnings6 .)

Strong Fitness Growth and New Product Push

The fitness division led all segments, with Q3 revenue up ~30% to $601 millionuk.investing.com. Garmin credited robust demand for advanced wearables. This success was bolstered by new launches: during the quarter Garmin launched the Venu 4 smartwatch (with a premium all-metal design and LED flashlight) and the Bounce 2 kids’ trackerprnewswire.com. The outdoor category saw a small decline (-5%) despite introducing the new fēnix 8 Pro satellite-connect watchprnewswire.com. The diversity paid off: aviation sales jumped +18%, marine +20%uk.investing.com. Garmin even launched a hands-free kayak motor and horse-monitoring system – reflecting its broad portfolio.

Tech media was bullish on Garmin’s product roadmap. For example, TechStock² notes that Garmin’s stock “saw a slight uptick” when the Venu 4 was announced, suggesting investor confidence in its innovationts2.tech. Cliff Pemble emphasized the company’s “strong lineup of innovative products” heading into the holiday seasonprnewswire.com. Garmin also reported strong cash generation (about $486M operating cash flow) and a $300M buyback program, signaling financial health7 .

Analysts and Price Targets: Mixed Signals

Analysts remain split on Garmin’s stock. The most bullish calls point to the company’s growth engine: Tigress Financial’s Ivan Feinseth keeps a strong-buy on Garmin, raising his 12-month target to $305tipranks.com (over 20% above current levels) due to “accelerating revenue growth… in fitness and wearables.” Morgan Stanley and JP Morgan have also lifted their targets this year (to $193 and $250 respectively)marketbeat.com. In contrast, other analysts are cautious – the median target among 19 forecasts is just $210tickernerd.com. MarketBeat notes a consensus “Hold” rating with an average target near $228marketbeat.com. In short, some see strong upside if Garmin’s products continue selling, while others feel much of that optimism is already priced in.

Legal Spotlight – Strava vs. Garmin Lawsuit

Adding drama, Garmin faces a high-stakes legal battle. In late September fitness-platform Strava sued Garmin, claiming Garmin copied Strava’s patented “segments” (time-based route challenges) and “heatmap” featurests2.tech. Strava is even seeking an injunction to stop Garmin selling any device or service with those features (which could affect nearly all of Garmin’s fitness watches and cycling computers)ts2.tech. Industry analysts warn this suit is “high-stakes” – Strava is a $2.2 billion app company aiming for an IPO, and the case “could redefine the balance of power between fitness platforms and the device makers”ts2.tech. Garmin has declined detailed comment, but this risk will be closely watched by investors, since any ban on core features would hurt Garmin’s biggest market.

Looking Ahead: Outlook and Forecasts

With Garmin’s stock around the mid-$200s, the outlook hinges on execution. Experts will watch holiday sales (how well Venu 4, fēnix 8 Pro and other products sell) and whether guidance holds. The company now foresees ~$8.15 EPS for FY2025prnewswire.com, above prior consensus, reflecting confidence. Yet the mixed analyst price targets (from $167 up to $305) underscore a divided market. In the near term, technical analysts see support near $240 and resistance around $260. In summary, Garmin’s fundamentals (diversified business, new products, buybacks) remain strong, but investors will want reassurance that growth can continue in a crowded wearables market and that legal risks stay contained.

Sources: Garmin Q3 press releaseprnewswire.comprnewswire.com; Associated Press/Q3 snapshottimesunion.comtimesunion.com; Investing.com market reportuk.investing.comuk.investing.com; AskTraders analysisasktraders.comasktraders.com; TipRanks newstipranks.comtipranks.com; TechStock² coveragets2.techts2.tech; MarketBeat/Weiss Ratingsmarketbeat.com; tickernerd analyst summary8 .

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
2025’s Best-Performing Stock Market Is Up 35% – Here’s What’s Driving the Rally
Previous Story

2025’s Best-Performing Stock Market Is Up 35% – Here’s What’s Driving the Rally

No More Buttons?! iPhone 20 Leak Teases Radical 2027 Redesign & Camera Shake-Up
Next Story

No More Buttons?! iPhone 20 Leak Teases Radical 2027 Redesign & Camera Shake-Up

Go toTop